Table 4.
Response summary
| Best response to AFM13, efficacy population (n = 26) | Patients, n (%) |
|---|---|
| Complete remission | 0 (0.0) |
| Partial response | 3 (11.5) |
| Stable disease | 13 (50.0) |
| Progressive disease | 10 (38.5) |
| Disease control rate | 61.5 |
Response summary
| Best response to AFM13, efficacy population (n = 26) | Patients, n (%) |
|---|---|
| Complete remission | 0 (0.0) |
| Partial response | 3 (11.5) |
| Stable disease | 13 (50.0) |
| Progressive disease | 10 (38.5) |
| Disease control rate | 61.5 |